These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14871026)

  • 1. Neuropeptide Y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery.
    Tsurumaki T; Honglan P; Higuchi H
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S33-7. PubMed ID: 14871026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
    Bergdahl A; Nilsson T; Cantera L; Nilsson L; Sun XY; Hedner T; Erlinge D; Valdemarson S; Edvinsson L
    Eur J Pharmacol; 1996 Nov; 316(1):59-64. PubMed ID: 8982651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked neuropeptide Y-induced contractions via NPY-Y1 receptor and its desensitization in rat veins.
    Tsurumaki T; Yamaguchi T; Higuchi H
    Vascul Pharmacol; 2002 Dec; 39(6):325-33. PubMed ID: 14567071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
    Zhao XH; Sun XY; Bergdahl A; Edvinsson L; Hedner T
    J Pharm Pharmacol; 1999 Nov; 51(11):1257-65. PubMed ID: 10632083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
    Duckles SP; Adner M; Edvinsson L; Krause DN
    Eur J Pharmacol; 1997 Dec; 340(1):75-9. PubMed ID: 9527509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
    Gicquiaux H; Tschöpl M; Doods HN; Bucher B
    Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
    Barrios VE; Nelson AG; Toombs CF
    Life Sci; 1998; 62(6):525-32. PubMed ID: 9464464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-induced contraction and its desensitization through the neuropeptide Y receptor subtype in several rat veins.
    Tsurumaki T; Muraoka O; Yamaguchi T; Higuchi H
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S23-7. PubMed ID: 12688392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
    Bergdahl A; Nilsson T; Sun XY; Hedner T; Edvinsson L
    Eur J Pharmacol; 1998 Nov; 360(2-3):165-73. PubMed ID: 9851583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.
    Jacques D; Cadieux A; Dumont Y; Quirion R
    Eur J Pharmacol; 1995 May; 278(1):R3-5. PubMed ID: 7664808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
    Grundemar L; Ekelund M
    Pharmacol Toxicol; 1996 Nov; 79(5):266-9. PubMed ID: 8936561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
    Nilsson T; Erlinge D; Cantera L; Edvinsson L
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):764-8. PubMed ID: 8961073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries.
    Nilsson T; Cantera L; Edvinsson L
    Neurosci Lett; 1996 Feb; 204(3):145-8. PubMed ID: 8938251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.